CareDx Announces New Chief Commercial Officer Todd Whitson
March 29, 2016 13:04 ET
|
CareDx, Inc.
BRISBANE, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Announces CFO Transition
March 24, 2016 16:02 ET
|
CareDx, Inc.
BRISBANE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results
March 24, 2016 16:01 ET
|
CareDx, Inc.
BRISBANE, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx to Announce Fourth Quarter and 2015 Year-End Financial Results on March 24 and Will Present at the 28th Annual Roth Conference on March 16
March 10, 2016 07:30 ET
|
CareDx, Inc.
BRISBANE, Calif., March 10, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Receives Positive Coverage Decision for AlloMap® From TRICARE® Covering Over 9 Million Lives of U.S. Military Members and Their Families
March 08, 2016 07:30 ET
|
CareDx, Inc.
BRISBANE, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Announces Revised Timeline to Its Offer to Acquire Allenex
February 29, 2016 02:26 ET
|
CareDx, Inc.
BRISBANE, Calif., Feb. 29, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx Announces Revised Agreement to Purchase 78 Percent of the Outstanding Shares of Allenex AB and Plans to Launch Tender for Remaining Shares in First Quarter 2016
February 09, 2016 03:01 ET
|
CareDx, Inc.
BRISBANE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx to Participate in Upcoming Healthcare Conferences in February 2016: Leerink, BIO CEO & BTIG
February 02, 2016 16:37 ET
|
CareDx, Inc.
BRISBANE, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap® Test in Europe
January 12, 2016 16:05 ET
|
CareDx, Inc.
BRISBANE, Calif. and PARIS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
UPDATE: CareDx Completes Analytical Validation of AlloSure: A Next-Generation Sequencing Test Measuring Donor-Derived Cell-Free DNA in Transplant Patients
December 23, 2015 20:28 ET
|
CareDx, Inc.
BRISBANE, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...